fda compounding semaglutide warning letters october 2025 New project announcement: HHS‑OIG is taking a closer look at FDA's oversight of compounded GLP‑1 drugs. Although shortages ended in 2025, some facilities may still be producing these drugs at scale. Our FDA telehealth crackdown highlights role

Weight loss on a GLP-1 typically starts in the first month, picks up during dose escalation, and plateaus around 1214 months

Use code: STARTGLP1

STEP 3 Cover with foil, place on baking sheet and bake for 20 minutes

FDA-Approved Medication, Prescribed After Labs Compounded GLP-1s sold online are under active FDA enforcement

In particular, through structured programs or intensive lifestyle interventions, as demonstrated in the STEP 3 trial and supported by the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society. Start losing weight on semaglutide

This weight loss medication also slows down the rate at which the stomach empties, improving blood sugar control